Abstract PD03-09: Statins and breast cancer risk: A follow-up analysis of the Women's Health Initiative Cohort

Simvastatin was associated with a reduced risk of invasive breast cancer, and as a class, lipophilic statins were associated withA marginal benefit, providing further evidence for possible class differences in statins with regard to chemo-preventive effects in breast cancer.